Skip to main content

Table 4 Percentage of patients with improved BMLs

From: Clinical effect of intramuscular calcitonin compared with oral celecoxib in the treatment of knee bone marrow lesions: a retrospective study

 

Calcitonin (n = 66)

Celecoxib (n = 57)

P value

4 weeks

14 (21.21%)

4 (7.01%)

0.039

3 months

25 (37.88%)

9 (15.79%)

0.006

  1. BMLs bone marrow lesions